Walleye Capital’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $210K | Buy |
+11,818
| New | +$210K | ﹤0.01% | 1362 |
|
|
2025
Q1 | – | Sell |
-23,878
| Closed | -$712K | – | 2204 |
|
|
2024
Q4 | $712K | Buy |
23,878
+21,961
| +1,146% | +$654K | ﹤0.01% | 1045 |
|
|
2024
Q3 | $30K | Sell |
1,917
-8,281
| -81% | -$129K | ﹤0.01% | 2077 |
|
|
2024
Q2 | $175K | Sell |
10,198
-41,502
| -80% | -$711K | ﹤0.01% | 1909 |
|
|
2024
Q1 | $808K | Sell |
51,700
-60,383
| -54% | -$944K | ﹤0.01% | 1154 |
|
|
2023
Q4 | $1.67M | Sell |
112,083
-23,564
| -17% | -$352K | ﹤0.01% | 708 |
|
|
2023
Q3 | $2.19M | Buy |
135,647
+95,647
| +239% | +$1.54M | 0.01% | 627 |
|
|
2023
Q2 | $1.66M | Buy |
+40,000
| New | +$1.66M | 0.01% | 570 |
|
|
2023
Q1 | – | Sell |
-7,308
| Closed | -$536K | – | 2538 |
|
|
2022
Q4 | $536K | Buy |
+7,308
| New | +$536K | 0.01% | 967 |
|
|
2022
Q3 | – | Sell |
-2,972
| Closed | -$207K | – | 2592 |
|
|
2022
Q2 | $207K | Buy |
+2,972
| New | +$207K | 0.01% | 1473 |
|
|
2020
Q4 | – | Sell |
-2,128
| Closed | -$237K | – | 1046 |
|
|
2020
Q3 | $237K | Buy |
+2,128
| New | +$237K | 0.03% | 551 |
|
|
2019
Q4 | – | Sell |
-8,204
| Closed | -$613K | – | 948 |
|
|
2019
Q3 | $613K | Sell |
8,204
-1,529
| -16% | -$114K | 0.04% | 75 |
|
|
2019
Q2 | $615K | Buy |
9,733
+8,223
| +545% | +$520K | 0.07% | 36 |
|
|
2019
Q1 | $73K | Buy |
+1,510
| New | +$73K | 0.01% | 187 |
|